Immatics-posted 3 days ago
Full-time • Executive
Remote • Houston, TX
501-1,000 employees

Join Immatics and shape the future of cancer immunotherapy; one patient at a time! Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. Why Join Us? Innovative Environment: Help to pioneer advancements in cancer immunotherapy. Collaborative Culture: Be part of a diverse team dedicated to your professional growth. Global Impact: Contribute to therapies that make a lasting impact on patients globally. We are seeking an accomplished and strategic Vice President of Launch Excellence to lead the end-to-end planning and execution of a first-in-class TCR-T cell therapy launch in melanoma.

  • Develop and own the global launch plan for the TCR-T cell therapy, including short- and long-term milestones.
  • Translate strategic imperatives into operational execution across geographies and functions.
  • Serve as the cross-functional launch lead, coordinating Commercial, Medical Affairs, Regulatory, Market Access, Manufacturing, and Clinical teams.
  • Chair the launch excellence governance committee and ensure all workstreams are on track.
  • Foster collaboration between early-stage development teams and late-stage commercial functions.
  • Align internal and external stakeholders (e.g., co-commercialization entities) around shared launch goals.
  • Partner with Commercial, Medical & CMC teams to define the ideal patient journey and treatment algorithm for TCR-T in melanoma.
  • Guide creation of field force strategy, segmentation, targeting, and deployment models.
  • Drive operational launch readiness including supply chain, QA, and manufacturing logistics, especially given the personalized and complex nature of TCR-T therapy.
  • Establish and track launch KPIs, success metrics, and risk mitigation strategies.
  • Ensure compliance and regulatory readiness across launch markets.
  • Collaborate with Market Access to shape pricing, reimbursement, and health economics strategies.
  • 15+ years of biopharma experience with at least 10 years in oncology; cell/gene therapy a must.
  • Proven track record of at least one successful US cell therapy product launch.
  • Deep understanding of the melanoma treatment landscape, therapeutic decision-making, and patient access barriers.
  • Demonstrated leadership in cross-functional teams and launch readiness governance.
  • Strong strategic planning, operational execution, and change management skills.
  • Excellent communication and influencing ability across executive and functional teams.
  • Advanced degree in life sciences, medicine, or business (MBA, PhD, MD, or equivalent).
  • Experience with TCR, CAR-T, or TIL cell therapies.
  • Knowledge of personalized manufacturing and vein-to-vein logistics.
  • Familiarity with digital launch excellence tools and analytics.
  • Competitive rates for Health, Dental, and Vision Insurance
  • 4 weeks of Paid Time off, granted up front each year and prorated for first and last year of employment.
  • Sick Time Off – 56 hours
  • 12 Paid Holidays
  • 100% Employer-Paid Life Insurance up to at 1x annual salary
  • 100% Employer Paid Short- and Long-Term Disability Coverage
  • 401(k) with Immediate Eligibility & company match… You are eligible for 401(k) plan participation as of your first paycheck. The company will match 100% of your contributions up to 3% of your base salary for the first two years of employment, 4% for years 2-3 of employment, and up to 5% of your salary from the fourth year onward of continued employment.
  • Partially paid Parental Leave for eligible employees. (3 weeks)
  • Additional voluntary employee paid coverages including Accident, Hospital Indemnity, and Critical Illness
  • Employee Paid Identity Theft Protection and Pet Insurance
  • Opportunities to work with leading experts in the field of T-cell immunotherapy.
  • Company provided learning and development opportunities
  • Fast paced, high demand collaborative and dynamic environment.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service